Global Aortic Endograft Market Size
Medical Equipment

Aortic Endograft Market Growth Analysis Till 2033 By The Business Research Company

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Strong Historical Growth

  • Market Size: Grew from $3.14 billion in 2023 to $3.35 billion in 2024.
  • CAGR: 6.7%.
  • Key Drivers:
    • Growth in medical tourism.
    • Increasing need for aortic aneurysm management.
    • Rising number of aortic aneurysm cases.
    • Technical success of endograft implantation.
    • Increase in the number of hospitals.

Promising Future Outlook

  • Expected Growth: Projected to reach $4.08 billion by 2028.
  • CAGR: 5.1%.
  • Key Drivers:
    • Increasing prevalence of abdominal aortic aneurysm.
    • Growing preference for minimally invasive procedures.
    • Rising geriatric population.
    • Advancements in stent-graft materials and configurations.
    • Introduction of new stent-graft products.

Read More On The Aortic Endograft Market Report 2024 –

Market Trends and Innovations

  • Trends:
    • Adoption of endovascular abdominal aortic aneurysm (AAA) repair devices.
    • Effectiveness of unibody and non-unibody aortic stents.
    • Product innovation.

Rising Incidence of Aortic Aneurysms

  • Aortic Aneurysms: Localized dilation or bulging of the aorta.
  • Treatment: Aortic endografts are less invasive than traditional surgery, involving a fabric-covered metal or polymer device inserted via a catheter.
  • Screening Statistics: In the UK, 274,800 men were screened between April 2021 and March 2022, identifying 1,794 aneurysms.

Key Players in the Market

  • Major Companies:
    • Cardinal Health Inc.
    • Abbott Laboratories
    • Medtronic Plc
    • Becton, Dickinson and Company
    • Koninklijke Philips N.V.
    • Boston Scientific Corporation
    • Terumo Corporation
    • W. L. Gore & Associates Inc.
    • Cook Medical Inc.
    • Merit Medical Systems Inc.
    • Penumbra Inc.
    • LifeTech Scientific Corporation
    • Altura Medical Inc.
    • MicroVention Inc.
    • MicroPort Scientific Corporation
    • CryoLife Inc.
    • Cordis Corporation
    • Endologix LLC

Innovations in Medical Devices

  • Castor-Branched Aortic Stent Graft System:
    • Manufacturer: Shanghai MicroPort Endovascular MedTech Group Co. Ltd.
    • Launch: December 2021.
    • Features: Minimally invasive repair of aorta and aortic arch, especially in Stanford type B aortic dissection (TBAD). Unique unibody design conforming to diverse arch anatomies, offering one-time access and release, and promoting long-term stability.

Strategic Acquisitions

  • Endologix LLC: Acquired PQ Bypass Inc. in April 2021.
    • Objective: Expand and reinforce its position in abdominal aortic aneurysm treatment.
    • PQ Bypass Inc.: US-based medical device company specializing in aortic endografts.

Market Segmentation

  • By Product:
    • Abdominal Aortic Grafts.
    • Thoracic Aortic Grafts.
  • By Material:
    • Metallic Endografts.
    • Polymeric Endografts.
  • By Procedure:
    • Open Surgical Repair.
    • Endovascular Aneurysm Repair (EVAR).
  • By End User:
    • Hospitals.
    • Ambulatory Surgical Centers.

Regional Insights

  • Largest Region (2023): North America.
  • Fastest-Growing Region (Forecast Period): Asia-Pacific.

Request for A Sample Of The Global Aortic Endograft Market Report: